Lorena M. Coria

发表

An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice

Fernanda S. Oliveira, S. Oliveira, H. Warzecha, 2011, PloS one.

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

S. Estein, C. A. Fossati, G. Giambartolomei, 2008, Infection and Immunity.

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System

D. Comerci, Francisco Guaimas, J. Cassataro, 2019, Front. Immunol..

The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis

Fernanda S. Oliveira, J. Borkowski, S. Oliveira, 2010, The Journal of Immunology.

The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.

F. Paolicchi, F. Goldbaum, S. Estein, 2009, Vaccine.

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice

S. McSorley, G. Briones, Seung‐Joo Lee, 2017, Front. Immunol..

T Cells + and CD4 Cells Breast Cancer Growth Mediated by NK Therapeutic Immune Responses against Cells and Elicits Prophylactic and Targeting Stat3 Induces Senescence in Tumor

I. Frahm, M. Tkach, W. Béguelin, 2012 .

Brucella abortus induces TNF-α-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases

M. Delpino, P. Baldi, G. Giambartolomei, 2013, Journal of Neuroinflammation.

A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection

Lucía B. Chemes, D. Alvarez, Julieta Alcain, 2021, bioRxiv.

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

M. Tkach, R. Schillaci, A. Trevani, 2016, The Journal of Immunology.

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

Francisco Guaimas, J. Cassataro, Karina A. Pasquevich, 2019, Journal of controlled release : official journal of the Controlled Release Society.

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19

Lucía B. Chemes, Rodolfo M. Rasia, J. Cassataro, 2022, Computational and structural biotechnology journal.

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

J. Cassataro, Karina A. Pasquevich, Lorena M. Coria, 2020, Vaccine.

Brucella abortus induces apoptosis of human T lymphocytes.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2012, Microbes and infection.